176 related articles for article (PubMed ID: 22183703)
1. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
3. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II--Lupus anticoagulant.
Favaloro EJ; Bonar R; Marsden K
Semin Thromb Hemost; 2012 Jun; 38(4):404-11. PubMed ID: 22565408
[TBL] [Abstract][Full Text] [Related]
4. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
[TBL] [Abstract][Full Text] [Related]
5. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants.
Moore GW
Semin Thromb Hemost; 2014 Mar; 40(2):163-71. PubMed ID: 24500573
[TBL] [Abstract][Full Text] [Related]
6. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants.
Arnout J
Thromb Haemost; 2001 Jul; 86(1):83-91. PubMed ID: 11487046
[TBL] [Abstract][Full Text] [Related]
8. Measurement of lupus anticoagulants: an update on quality in laboratory testing.
Adams M
Semin Thromb Hemost; 2013 Apr; 39(3):267-71. PubMed ID: 23424052
[TBL] [Abstract][Full Text] [Related]
9. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
Court EL
Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
[TBL] [Abstract][Full Text] [Related]
10. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
[TBL] [Abstract][Full Text] [Related]
11. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
[TBL] [Abstract][Full Text] [Related]
12. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
Moore GW; Rangarajan S; Savidge GF
Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
[TBL] [Abstract][Full Text] [Related]
13. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices.
Moffat KA; Ledford-Kraemer MR; Plumhoff EA; McKay H; Nichols WL; Meijer P; Hayward CP
Thromb Haemost; 2009 Jan; 101(1):178-84. PubMed ID: 19132206
[TBL] [Abstract][Full Text] [Related]
14. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
[TBL] [Abstract][Full Text] [Related]
15. To mix or not to mix in lupus anticoagulant testing? That is the question.
Tripodi A
Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
[TBL] [Abstract][Full Text] [Related]
16. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
[TBL] [Abstract][Full Text] [Related]
17. Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I.
Arnout J; Meijer P; Vermylen J
Thromb Haemost; 1999 Jun; 81(6):929-34. PubMed ID: 10404770
[TBL] [Abstract][Full Text] [Related]
18. Lupus anticoagulants: diagnostic dilemma and clinical challenge.
Triplett DA
Clin Lab Sci; 1997; 10(4):223-8. PubMed ID: 10169622
[TBL] [Abstract][Full Text] [Related]
19. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
Moore GW; Platton S; Yartey N; Foxton E; White D; MacDonald SG
Int J Lab Hematol; 2024 Jun; 46(3):538-545. PubMed ID: 38303489
[TBL] [Abstract][Full Text] [Related]
20. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
